Normal view MARC view ISBD view

A meta-analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile. [electronic resource]

By:

Phimarn, Wiraphol

Contributor(s):

Producer: 20180419Description: 1509-1521 p. digitalISSN:

1436-6215

Subject(s):

Online resources:

Available from publisher's website

In: European journal of nutrition vol. 56

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Meta-Analysis; Review

There are no comments on this title.

to post a comment.

Back to results

61 Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response.
by Brouwers, Adrienne H
62 Manipulation of [11C]-5-hydroxytryptophan and 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine accumulation in neuroendocrine tumor cells.
by Neels, Oliver C
63 False-positive findings on 6-[18F]fluor-l-3,4-dihydroxyphenylalanine PET (
by Berends, Annika M A
64 Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma.
by Brouwers, Adrienne H
65 Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma.
by Klein Hesselink, Esther N
66 89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.
by Gaykema, Sietske B M
67 Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study.
by van der Horst-Schrivers, Anouk N A
68 Comparative biodistribution analysis across four different
by Bensch, Frederike
69 Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
by van Asselt, Sophie J
70 NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
by Klein Hesselink, Esther N
71 Potential value of EUS in pancreatic surveillance of VHL patients.
by van Asselt, Sophie J
72 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
by Fiebrich, Helle-Brit
73 VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients.
by Nagengast, Wouter B
74 VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment.
by Nagengast, Wouter B
75 89Zr-bevacizumab PET imaging in primary breast cancer.
by Gaykema, Sietske B M
76 Interobserver reproducibility of tumor uptake quantification with
by Jauw, Yvonne W S
77 EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
by van Asselt, Sophie J
78 None
by Bensch, Frederike
79 89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.
by Oosting, Sjoukje F
80 89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.
by Oosting, Sjoukje F